We further reported a nonsense mutation SCN2A-R102* (RX) in a patient with epileptic encephalopathy, autism spectrum disorder (ASD) and intellectual disability4, which was the first report of a de novo SCN2A mutation in a patient with ASD or intellectual disability. Here, SCN2A is linked to Epileptic encephalopathy.